<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F8E9ECC5-8F64-48A0-9783-90D9D1F2FBC4"><gtr:id>F8E9ECC5-8F64-48A0-9783-90D9D1F2FBC4</gtr:id><gtr:name>MRC Health Services Resrch Collaboration</gtr:name><gtr:address><gtr:line1>University of Bristol</gtr:line1><gtr:line2>Canynge Hall</gtr:line2><gtr:line3>Whiteladies Road</gtr:line3><gtr:line4>Bristol</gtr:line4><gtr:postCode>BS8 2PR</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F8E9ECC5-8F64-48A0-9783-90D9D1F2FBC4"><gtr:id>F8E9ECC5-8F64-48A0-9783-90D9D1F2FBC4</gtr:id><gtr:name>MRC Health Services Resrch Collaboration</gtr:name><gtr:address><gtr:line1>University of Bristol</gtr:line1><gtr:line2>Canynge Hall</gtr:line2><gtr:line3>Whiteladies Road</gtr:line3><gtr:line4>Bristol</gtr:line4><gtr:postCode>BS8 2PR</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/00FD6AA2-05F7-496D-B825-61F2CD8CDD16"><gtr:id>00FD6AA2-05F7-496D-B825-61F2CD8CDD16</gtr:id><gtr:firstName>A E</gtr:firstName><gtr:surname>Ades</gtr:surname><gtr:orcidId>0000-0001-7822-3552</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U145079307"><gtr:id>6A2A3F5F-F830-4F1D-B1F4-E63869AF8AEA</gtr:id><gtr:title>Multi-parameter Evidence Synthesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U145079307</gtr:grantReference><gtr:abstractText>It is essential that treatment recommendations and public health policy decisions made by the Department of Health and the NHS are able to attract widespread support. This requires that the methodology used to reach decisions is transparent, open to debate, and able to attract consensus among manufacturers, managers, doctors, and experts.||These decisions rely on models. Model credibility, in turn, requires that all the available evidence is used to drive the model, and that all uncertainties in the evidence are propagated carefully through the model.||The role of this programme is to advance the methodology for evidence synthesis, so that it matches these aspirations. Critical issues are: how to combine multiple sources of evidence informing multiple functions of model parameters, and how to detect and address inconsistencies in the evidence base. If multiple, interlocking evidence sources can be shown to be consistent, then the ability to incorporate information on functions of parameters will increase the precision of model parameters, reduce uncertainty in decision, enhance the credibility of decisions, and reduce the need for further research.|||</gtr:abstractText><gtr:technicalSummary>Our focus is the development and dissemination of statistical methods for evidence synthesis. Standard meta-analysis has been seen as a way of summarising the literature on a single parameter. However, decision problems may involve several treatments, and the evidence available may involve a range of different outcomes, in studies of different designs. In particular, evidence may be available both on model parameters and on multiple functions of parameters. Therefore, in contrast to standard decision analytic methods, in which each parameter is informed by a separate study or meta-analysis, there are invariably either fewer, or (more often) more data sources than there are parameters, leading to a redundancy of information. This creates an opportunity to assess whether different sources of data are consistent with each other, and thus to validate decision models in a formal way. ||The programme has five planks:||1. Synthesis issues raised by generic evidence structures. We are working on: Mixed treatment comparisons; Markov models, and multiple and surrogate outcomes; treatment combinations; and epidemiological models for prevalence and incidence. In choosing which structures to work on, we give emphasis to synthesis problems recurring at the NICE appraisals process. In addition, collaborations in epidemiology and public health (below) expose us to further evidence structures. ||2. Recurring theoretical problems. Evidence consistency is a major focus. We are investigating a range of global and local diagnostics to identify inconsistency between evidence sources, given a particular model. A second focus is Expected Value of Information methodology. The challenge is to devise computational methods that are compatible with the correlated parameter distributions output from MPES. ||3. Substantive projects. Alongside the MRC programme are a series of substantive projects, funded independently at Bristol, or involving collaborations outside: incidence and prevalence of HIV in the UK, the prevalence of HCV and drug use, toxoplasmosis incidence, screening for congenital toxoplasmosis, screening for Group B Streptococcus. ||4. Dissemination strategy. In publications and conference attendance, we separately target 3 communities: health economics/decision analysis, epidemiology/biostatistics, and EBM/systematic review, in communities . Our five-day course Evidence Synthesis for Decision Making, jointly run with colleagues at Leicester, which will have had three runs during 2005, allows both groups to show-case practical worked examples to CEA practitioners, statisticians, and systematic reviewers. ||5. A national collaborative network Beyond the bilateral collaborative relationships, we are attempting to grow a wider collaboration - eventually with a broader funding base - as an efficient way to develop and refine these methods and increase their use, based on a wider strategy for development of MRC funding Health Services Research in the UK.</gtr:technicalSummary><gtr:fund><gtr:end>2007-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>211402</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Biostatistics Unit</gtr:department><gtr:description>MRC Biostatistics</gtr:description><gtr:id>89E1DD33-370D-44A0-99E8-2C34F02C6410</gtr:id><gtr:impact>see publications list, publications with S Dias as first author</gtr:impact><gtr:outcomeId>TAnt8asEvnU-1</gtr:outcomeId><gtr:partnerContribution>Collaboration with Julian Higgins has lead to our obtaining MRC funding (Population Health Sceince Research Network 14) for &amp;quot;optimisIng INFORMATION FROM rANDOMISED cONTROLLED tRIALS

It has also lead to collaborative work on Inconsistency with JUlian Higgins and Ian White

It has also lead to work with Julian Higgins, Ian White and others on Missing data in meta-analysis</gtr:partnerContribution><gtr:piContribution>We have contributed theory and illustrative analyses on use of network meta-analysis in identifying and adjusting for types of bias in RCTs

We have contributed methodology on assessment of inconsistency in networks of RCTs</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Epidemiology and Public Health</gtr:department><gtr:description>Leicester</gtr:description><gtr:id>986FAF20-F613-43BC-8A60-138ECE713F78</gtr:id><gtr:impact>listed in main section</gtr:impact><gtr:outcomeId>4DB4FBA974A-1</gtr:outcomeId><gtr:partnerContribution>Collaborators (Prof Keith Abrams, Prof Alex Sutton, Dr Nicola Cooper have contributed intellectually to a number of our lines of research. This is reflected in a number of co-authored publications. The collaborators expertise in evidence synthesis and Bayesian methods made them excellent partners in the short course programme we now jointly run. One of the MRC HSRC studentships was placed in Univ Leicester, with Prof Alex Sutton as the main supervisor, I was a co-supervisor. Publications are listed in first section.</gtr:partnerContribution><gtr:piContribution>see collabator details</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>NICE - ABPI Masterclassess</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>585B284B-7A05-47D4-9571-3E07A77D90A6</gtr:id><gtr:impact>We have put on the Evidence Synthesis part of general masterclasses on &amp;quot;what make a good submission&amp;quot;, and we have also designed and presented masterclasses that focus entirely on evidence synthesis in the NICE context

.</gtr:impact><gtr:outcomeId>sZvJN3oVuFx</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NICE Clincial Guidelines</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B627B661-879F-41BD-BA88-36A36B09C2D0</gtr:id><gtr:impact>As a result it was possible for guideline development groups to make coherent clinical and cost-effectiveness comparisons between several treatments, based on all the available evidence.
This is not possible with the use of methods we have pioneered

Partly arising from this work, the group has won a 3-year contract to supply a Technical Support Unit to the NICE Clinical Guidelines development process</gtr:impact><gtr:outcomeId>Th2aqwgsqEM</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009,2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Public Health (Cancer Screening)</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>5FB8F1B1-F51A-475C-A00B-CDD5CAC43D74</gtr:id><gtr:outcomeId>0C0643C43C20</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>NIHR HTA (08/70)</gtr:description><gtr:end>2010-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>1F2C24A7-0662-47D3-BA10-454A23A8367B</gtr:id><gtr:outcomeId>A886F6D926D0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC NIQUAD Cluster, Addiction</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>33CCAF2A-3D5C-4D94-876D-D29B3853D9A6</gtr:id><gtr:outcomeId>tecpDqxH2oZ0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC G0801947</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F49F21F6-303E-4152-A119-1E635A05DCAE</gtr:id><gtr:outcomeId>ntfNTs9ZdUS0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NICE contract to supply Technical Support Unit</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>National Institute for Health and Care Excellence (NICE)</gtr:fundingOrg><gtr:id>90AFBAC9-BFA4-4A13-A9BA-4C54A98903D5</gtr:id><gtr:outcomeId>XCSekqGbkvL</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Population Health Sciences Research Network (PHSRN) funding</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8211BA82-64AE-41D9-8574-79FD863816E0</gtr:id><gtr:outcomeId>EB0FADA93040</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Hubs for Trial Methodology Research (HTMR)</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>285AC21C-ECF9-4FC1-AA69-08F330232CD8</gtr:id><gtr:outcomeId>7C6638BF24F0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>NIHR HTA (08/60)</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>36265458-FDBD-421C-972E-1DB546F263AE</gtr:id><gtr:outcomeId>32801708BB00</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC G0901488</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>591E59A5-A674-4D38-9431-796CE764CD91</gtr:id><gtr:outcomeId>HwErGFGR8jC0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Public Health (Domestic Violence)</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>6B643739-8A54-4C3A-A250-B7C1332C6DFE</gtr:id><gtr:outcomeId>8FC1BCA8EB30</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Research Panel</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1872A9DB-5B47-4C67-BA60-30E0EA655E42</gtr:id><gtr:outcomeId>56187AB08D50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Short Courses</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>8A030CEE-E475-4795-81F4-82DB2E487456</gtr:id><gtr:impact>The programme has lead to the development of the 5-day course &amp;quot;Bayesian Evidence Synthesis for Decision Making&amp;quot; and the 3-day course &amp;quot;Indirect and Mixed Treatment Comparisons&amp;quot;, which have been run once each year since 2004, with our collaborators at University of Leicester (Prof Keith Abrams, Prof Alex Sutton, Dr Nicola Cooper). These course have been given to 35-48 people on each occasion, an equal mixture of academic, government, and industry statisticians and health economists. We have also run additional 2- or 3-day courses for Pfizer and for National Institute of Health &amp;amp; Clinical Excellence (NICE) Clinical Guidelines Group. In addition we have run 1-day introductory courses on Mixed Treatment Comparisons for NICE, and Janssen-Cilag.</gtr:impact><gtr:outcomeId>F499DE81BC5</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The software described here grew out of the Multi-Parameter Evidence Synthesis programme, initially funded by MRC HSRC. The software developed over several years, and was developed by Nicky Welton, Guobing Lu, and Sofia Dias, who were all funded by MRC.

This software is available on the NICE Decision Support Unit Website (http://www.nicedsu.org.uk/) in the form of 7 Technical Support Documents on Evidence Synthesis.

These TSDs describe a core model that carries out pair-wise meta-analysis, synthesis of multi-arm trials, network meta-analysis and indirect comparisons without distinction (TSD-2)
The core model can be applied, in a modular way, to a wide range of Generalized Linear Models (TSD-2)
Software is also provided that can be used to check inconsistency in networks (TSD-4), and meta-regression in networks (TSD-3).

The same core software is available to be downloaded from the ISPOR website (International Society for Pharmaco-economic and Outcomes Research). It can be found in teh &amp;quot;Appendix&amp;quot; to http://www.sciencedirect.com/science/article/pii/S1098301511013283</gtr:description><gtr:id>BC5EE19E-7332-417D-8777-2E02B56FA46A</gtr:id><gtr:impact>The software offers users a methodology that conforms to the requirements set out in the 2008, 2012 NICE Methods Guides.
It also conforms to the specifications described in the ISPOR Task Force report on Indirect comparisons and Network Meta-analysis
This software is used in a very large proportion of Submissions to the National Institute of Health and Clinical Excellence Technical Appraisals process: specifically those that involve network meta-analysis. 
It is also used widely in NICE Clinical Guideline development</gtr:impact><gtr:outcomeId>jcdNMwf2xwN</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>WinBUGs software for Evidence Synthesis</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.nicedsu.org.uk/</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a methodology for estimating the numbers of HIV infected individual - including those not diagnosed - based on a wide range of inter-locking sources of data, both routine and ad hoc surveys. Unlike the &amp;quot;direct method&amp;quot; used previously The methods allow for appropriate statistical inference, uncertainty propagation and consistency checking (validation). The original work was carried out under an MRC Special Project grant funded under CESA, within the Bristol MPES programme. The software is openly available</gtr:description><gtr:id>C0878C72-DCD0-49F4-9D36-F9D0DFB487DA</gtr:id><gtr:impact>These methods have been used by the Health Protection Agency every year since 2007 to provide the official Department of Health estimates</gtr:impact><gtr:outcomeId>Jwu1KkCUSrH</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Estimates of HIV prevalence in the UK</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C5E7CBE0-0F29-4069-832F-3FA5D5F2ECC7</gtr:id><gtr:title>Symptom lead times in lung and colorectal cancers: what are the benefits of symptom-based approaches to early diagnosis?</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c48c5cc52c9107d25e6b436cc577c0b1"><gtr:id>c48c5cc52c9107d25e6b436cc577c0b1</gtr:id><gtr:otherNames>Biswas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>56c1b643ce8fe8.49461533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65758D51-44F9-4C7A-A849-D181E3E1894A</gtr:id><gtr:title>Validity of indirect comparisons in meta-analysis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd5f5a88b189727f08440f53ef02f97"><gtr:id>6dd5f5a88b189727f08440f53ef02f97</gtr:id><gtr:otherNames>Caldwell DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>C56D032F59D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFAD1A2B-8CBF-4744-B34B-11C4CBD7CDE9</gtr:id><gtr:title>Assessing Evidence Inconsistency in Mixed Treatment Comparisons</gtr:title><gtr:parentPublicationTitle>Journal of the American Statistical Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/708ada18da20f695ad331397095f2bf0"><gtr:id>708ada18da20f695ad331397095f2bf0</gtr:id><gtr:otherNames>Lu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>BC0DD8B9C7B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6C02371-9632-4F1D-A200-26E678CF5366</gtr:id><gtr:title>Combination of direct and indirect evidence in mixed treatment comparisons.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/708ada18da20f695ad331397095f2bf0"><gtr:id>708ada18da20f695ad331397095f2bf0</gtr:id><gtr:otherNames>Lu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>74F6148C9D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B102EB07-C8E2-4DFE-BF45-D57269E9B46A</gtr:id><gtr:title>No evidence of industry sponsorship bias in statin trials.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84348f89524b645c7587643627d4774d"><gtr:id>84348f89524b645c7587643627d4774d</gtr:id><gtr:otherNames>Naci H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>56c1bc71c14ac9.73984926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6A3DE82-9423-41AD-A41D-BBB87109CC1C</gtr:id><gtr:title>Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflict.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6a21002105f03f66eed67137e868864"><gtr:id>b6a21002105f03f66eed67137e868864</gtr:id><gtr:otherNames>Hickman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>54610b90e293b3.66680367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C5571B4-471D-49BF-AB0F-C8D9897E75CC</gtr:id><gtr:title>Checking consistency in mixed treatment comparison meta-analysis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>ghvEkGWDiq5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5A91AE2-27FA-42C1-8EB9-F16C234603A2</gtr:id><gtr:title>Why does health services research seem so hard to fund?</gtr:title><gtr:parentPublicationTitle>Journal of health services research &amp; policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2f2f56e81df9fc59c43f1333287f7ef"><gtr:id>a2f2f56e81df9fc59c43f1333287f7ef</gtr:id><gtr:otherNames>Dieppe P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1355-8196</gtr:issn><gtr:outcomeId>57B73829662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABFA368F-8656-4ABA-BD26-EF37DF3EAF85</gtr:id><gtr:title>Multiparameter evidence synthesis in epidemiology and medical decision-making.</gtr:title><gtr:parentPublicationTitle>Journal of health services research &amp; policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1355-8196</gtr:issn><gtr:outcomeId>E26C633A6F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB616110-2042-4F0B-8DAD-82C14AFD52E7</gtr:id><gtr:title>Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37d6429f3ff43f894abfe659f6810568"><gtr:id>37d6429f3ff43f894abfe659f6810568</gtr:id><gtr:otherNames>Moreno SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>AFE0A0F14D2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C0E2DC9-E906-438D-B369-6A1AAA4F8CAB</gtr:id><gtr:title>Evidence synthesis, parameter correlation and probabilistic sensitivity analysis.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>1D1344A5F21</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8EFACE1-0B21-4103-9948-8D84EA99A128</gtr:id><gtr:title>Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>73379DE6FE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7FB4771-AC87-4791-8D47-ECB188B3C7DF</gtr:id><gtr:title>Illicit and pharmaceutical drug consumption estimated via wastewater analysis. Part B: placing back-calculations in a formal statistical framework.</gtr:title><gtr:parentPublicationTitle>The Science of the total environment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ea4f380bdda00b56e830cfa03018a1"><gtr:id>93ea4f380bdda00b56e830cfa03018a1</gtr:id><gtr:otherNames>Jones HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0048-9697</gtr:issn><gtr:outcomeId>54610a2ca01855.80832566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EC8DB79-D24F-4ACA-905E-C3AE4ABF6F5D</gtr:id><gtr:title>Use of indirect and mixed treatment comparisons for technology assessment.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e16234f056b59eeefb02d76f0c702e0"><gtr:id>5e16234f056b59eeefb02d76f0c702e0</gtr:id><gtr:otherNames>Sutton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>1CBD523642C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CACE349C-58D4-4629-AA0A-B6532C2F623C</gtr:id><gtr:title>Minimal clinically important difference on the Beck Depression Inventory--II according to the patient's perspective.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d36da206f23e4c493f35af41192fc13"><gtr:id>5d36da206f23e4c493f35af41192fc13</gtr:id><gtr:otherNames>Button KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>56c1b6424dab80.31926329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20A839C9-4527-4541-B1A7-5B538D9FDE2C</gtr:id><gtr:title>Modeling the need for hip and knee replacement surgery. Part 2. Incorporating census data to provide small-area predictions for need with uncertainty bounds.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/766538433b036c5ae9f0f6974c0ce0c3"><gtr:id>766538433b036c5ae9f0f6974c0ce0c3</gtr:id><gtr:otherNames>Judge A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>BCF8BFB6C76</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9913AA50-2F2F-40FF-820E-29812FE0E5E9</gtr:id><gtr:title>Evidence synthesis for decision making 1: introduction.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>54610b912167d9.17020245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1DA35A6-B113-44C1-9836-4984FBF48530</gtr:id><gtr:title>Use of evidence in economic decision models: practical issues and methodological challenges.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5980a4ac6bee6701a23bfdadb2397e8d"><gtr:id>5980a4ac6bee6701a23bfdadb2397e8d</gtr:id><gtr:otherNames>Cooper NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>B4C1B03DD32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABACE8F0-D1C2-440B-A52C-40F1902F0544</gtr:id><gtr:title>Evidence synthesis assumes additivity on the scale of measurement: response to &amp;quot;Rank reversal in indirect comparisons&amp;quot; by Norton et al.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a43f1871207fb7f431f2cb0284c410db"><gtr:id>a43f1871207fb7f431f2cb0284c410db</gtr:id><gtr:otherNames>van Valkenhoef G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>54610b90bc9244.18533603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1DE71CC-025B-4F53-8D46-2FA95B60E00F</gtr:id><gtr:title>Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5980a4ac6bee6701a23bfdadb2397e8d"><gtr:id>5980a4ac6bee6701a23bfdadb2397e8d</gtr:id><gtr:otherNames>Cooper NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>B2571EAF484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0769A93E-5901-4C8B-9EA3-60D35C5DE529</gtr:id><gtr:title>Modeling between-trial variance structure in mixed treatment comparisons.</gtr:title><gtr:parentPublicationTitle>Biostatistics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/708ada18da20f695ad331397095f2bf0"><gtr:id>708ada18da20f695ad331397095f2bf0</gtr:id><gtr:otherNames>Lu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1465-4644</gtr:issn><gtr:outcomeId>FC33810CA0E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1DB83AB-4416-4E5E-B0B8-497A8EDEFC46</gtr:id><gtr:title>Network Meta-Analysis for Decision Making</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5aaa5939af8ea8.49350709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E551053-74B8-4C54-901C-ED33D45364D4</gtr:id><gtr:title>Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison.</gtr:title><gtr:parentPublicationTitle>Current medical research and opinion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53af5e4feadeaafd7a9676fee4cad351"><gtr:id>53af5e4feadeaafd7a9676fee4cad351</gtr:id><gtr:otherNames>Edwards SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-7995</gtr:issn><gtr:outcomeId>7B53DDEC1EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72723317-F5E3-4B45-8917-A2F5A0C6BCA5</gtr:id><gtr:title>Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis.</gtr:title><gtr:parentPublicationTitle>The lancet. Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71f01af3f6c909f75b01813d0b4c00d1"><gtr:id>71f01af3f6c909f75b01813d0b4c00d1</gtr:id><gtr:otherNames>Mayo-Wilson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2215-0366</gtr:issn><gtr:outcomeId>56c1bc713fc753.11555524</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88FCBF36-5A34-49C0-BBC6-2A8E447A935D</gtr:id><gtr:title>Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment: Choosing among Statins in Primary Prevention.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b506a7e8db659dd5bdd02695269326a6"><gtr:id>b506a7e8db659dd5bdd02695269326a6</gtr:id><gtr:otherNames>Tervonen T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>56c1b6427b0d26.53873323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F38C198D-FE64-4E70-864E-B7BBA9665A61</gtr:id><gtr:title>Correction: interpretation of random effects meta-analysis in decision models.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>979CD18657A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5191D3B-0892-43A3-9FD3-19CADE70B5ED</gtr:id><gtr:title>Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>56c1b6431213c6.34482123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AB3FCB3-481D-4CFB-8032-7DB7E089C4FD</gtr:id><gtr:title>Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b0df5909d25e9aeadb7e428e8fbeca8"><gtr:id>1b0df5909d25e9aeadb7e428e8fbeca8</gtr:id><gtr:otherNames>Burch J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>CD16ADF325B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E04833CA-B02F-4C95-BE36-7BFDB4A824D3</gtr:id><gtr:title>Perinatal folate-related exposures and risk of psychotic symptoms in the ALSPAC birth cohort.</gtr:title><gtr:parentPublicationTitle>Schizophrenia research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e35c477287fd3494cf9c01df215821"><gtr:id>08e35c477287fd3494cf9c01df215821</gtr:id><gtr:otherNames>Glaser B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0920-9964</gtr:issn><gtr:outcomeId>pm_12506_26_20418067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC35E68F-FB66-485A-811F-8DC4FF8FDA8E</gtr:id><gtr:title>A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.</gtr:title><gtr:parentPublicationTitle>Nicotine &amp; tobacco research : official journal of the Society for Research on Nicotine and Tobacco</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1462-2203</gtr:issn><gtr:outcomeId>9EA20613541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8034831-D088-438B-AAB4-92238EAD8305</gtr:id><gtr:title>Absolute or relative effects? Arm-based synthesis of trial data.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>56c1b642abc3c8.74967312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E59739AB-1D12-4E5D-BED6-11B745585BA1</gtr:id><gtr:title>Evidence synthesis for decision making 5: the baseline natural history model.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>54610b9197e611.14822129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7176617A-1806-424E-9A21-FD3DC15EC7AF</gtr:id><gtr:title>Network meta-analysis with competing risk outcomes.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>pm_12506_26_20825617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8671EFD-777B-4029-8EC7-48E7A5E50543</gtr:id><gtr:title>Models for potentially biased evidence in meta-analysis using empirically based priors</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72ae2fe192b41cb5e3c10df466797986"><gtr:id>72ae2fe192b41cb5e3c10df466797986</gtr:id><gtr:otherNames>Welton N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>34D35DCE2AE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2071D096-1502-4114-9F74-1DE3E071C016</gtr:id><gtr:title>Parameterization of treatment effects for meta-analysis in multi-state Markov models.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>pm_12506_26_20963750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15665461-AE7F-4D62-91A9-B798DD95B7D2</gtr:id><gtr:title>Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ea4f380bdda00b56e830cfa03018a1"><gtr:id>93ea4f380bdda00b56e830cfa03018a1</gtr:id><gtr:otherNames>Jones HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>54610a2cc49265.80376007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5766A76F-B66C-42AE-8F59-FC96A1EBF207</gtr:id><gtr:title>Study designs to detect sponsorship and other biases in systematic reviews.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>ADuwpXNuG1S</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A175C400-BCA1-4730-ACB0-0B91D92E5B31</gtr:id><gtr:title>Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a9831b6c4905cbc4fe621ec6055c777"><gtr:id>8a9831b6c4905cbc4fe621ec6055c777</gtr:id><gtr:otherNames>Colbourn T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>908827475EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEFA8F4F-820C-447E-A3F4-E670304DAD35</gtr:id><gtr:title>Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84348f89524b645c7587643627d4774d"><gtr:id>84348f89524b645c7587643627d4774d</gtr:id><gtr:otherNames>Naci H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>54610a2d452247.19306455</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31D2625A-BE3E-4C65-933C-CCC46991C385</gtr:id><gtr:title>Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Critical care (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/410b2df32adbc9d15ed167f05d421fba"><gtr:id>410b2df32adbc9d15ed167f05d421fba</gtr:id><gtr:otherNames>Soares MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1364-8535</gtr:issn><gtr:outcomeId>56c1bc71898914.51702299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7507FC4-8829-4F9A-9BC0-55849BADB9AB</gtr:id><gtr:title>Treatment comparisons for decision making: facing the problems of sparse and few data</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9c25d1f8a590c53bc5fb75092f4bd46"><gtr:id>e9c25d1f8a590c53bc5fb75092f4bd46</gtr:id><gtr:otherNames>Soares M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>583ec24e875399.12462687</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AC63EAD-7097-4CD3-A61E-97C1A4DAF73E</gtr:id><gtr:title>Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a43f1871207fb7f431f2cb0284c410db"><gtr:id>a43f1871207fb7f431f2cb0284c410db</gtr:id><gtr:otherNames>van Valkenhoef G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>56c1b642dcd4f6.59589729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4E35737-8BA2-4048-96DC-45F2C6272FCE</gtr:id><gtr:title>Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bd522716636d6c40c2c616ae992e297"><gtr:id>9bd522716636d6c40c2c616ae992e297</gtr:id><gtr:otherNames>White IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>CBA9FE9A3C4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65F5C876-0F44-4955-A788-2830226BF84F</gtr:id><gtr:title>Simultaneous comparison of multiple treatments: combining direct and indirect evidence.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd5f5a88b189727f08440f53ef02f97"><gtr:id>6dd5f5a88b189727f08440f53ef02f97</gtr:id><gtr:otherNames>Caldwell DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>BCBAB11F1F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54C3B243-AEA6-4D1F-84D6-81098E0B2C84</gtr:id><gtr:title>Model averaging in the presence of structural uncertainty about treatment effects: influence on treatment decision and expected value of information.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>pm_12506_26_21402291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77AB7133-9DFD-46A2-B519-5E53EC35EA03</gtr:id><gtr:title>Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37d6429f3ff43f894abfe659f6810568"><gtr:id>37d6429f3ff43f894abfe659f6810568</gtr:id><gtr:otherNames>Moreno SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>EA34EAAD1A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8BE9FDC-F8EE-46C8-8856-8B0BD5C18F78</gtr:id><gtr:title>Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost-effectiveness analysis.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>54610b91bd5436.50813513</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>605CC3C0-98C2-4788-A20D-5CBA0CF8281A</gtr:id><gtr:title>The Cost Effectiveness of Psychological and Pharmacological Interventions for Social Anxiety Disorder: A Model-Based Economic Analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42081eee82295d0b863707e655b59248"><gtr:id>42081eee82295d0b863707e655b59248</gtr:id><gtr:otherNames>Mavranezouli I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56c1b6439f3466.59530963</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB2F4778-A929-49BB-A9F4-73C63888460D</gtr:id><gtr:title>Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>54610b914bfdb4.89524754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07CC0AE3-88E6-4D39-AD99-0DA49944F601</gtr:id><gtr:title>Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>6AE153C92AD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE9375CC-32F2-49E0-846F-A75771FD52D1</gtr:id><gtr:title>Commentary: evidence synthesis and evidence consistency.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>91B00BB0D2E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22470742-58C5-4114-92E1-106DBF616591</gtr:id><gtr:title>Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84348f89524b645c7587643627d4774d"><gtr:id>84348f89524b645c7587643627d4774d</gtr:id><gtr:otherNames>Naci H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>54610b903640c8.32505653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEA5C3FA-816E-4F56-952B-B2956DE34501</gtr:id><gtr:title>Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>pm_12506_26_21859701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65D4D17E-60D2-49CB-A01E-83B456CA9AA8</gtr:id><gtr:title>Consistency between direct and indirect trial evidence: is direct evidence always more reliable?</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13645c07a180a522f538980c4be6a5f6"><gtr:id>13645c07a180a522f538980c4be6a5f6</gtr:id><gtr:otherNames>Madan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>pm_12506_26_21914518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCF5F5FB-81F3-4D77-BD81-B09D8482EE4C</gtr:id><gtr:title>Expected value of sample information for multi-arm cluster randomized trials with binary outcomes.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>54610a2c55a855.75475481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C50FE2CB-96DB-46DA-80C8-26CE7DC77BCC</gtr:id><gtr:title>Evidence synthesis for decision making 7: a reviewer's checklist.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>54610b91e61e32.67393698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49C85311-3102-403E-A917-2C51CA00E4D8</gtr:id><gtr:title>Expected value of sample information calculations in medical decision modeling.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>0ED29BD9BD8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>182EF62A-3D95-451A-8C85-12C18D58B911</gtr:id><gtr:title>NICE DSU Technical Support Document 18: Methods for population-adjusted indirect comparisons in submissions to NICE</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c74b2141482ef5f7f0a94a11c2a4c693"><gtr:id>c74b2141482ef5f7f0a94a11c2a4c693</gtr:id><gtr:otherNames>Phillippo, D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c68bdf706412.76753868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E56546C-9DF9-43EF-95C9-3B0194285B19</gtr:id><gtr:title>Estimation of markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>9EA710C241E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEB90E01-486E-4BD2-AB38-F69ACA4A7A97</gtr:id><gtr:title>Indirect and mixed treatment comparisons in arthritis research.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>pm_12506_26_21859707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4199428-FE08-4E47-95A2-9E245CCDF58C</gtr:id><gtr:title>Evaluation of networks of randomized trials.</gtr:title><gtr:parentPublicationTitle>Statistical methods in medical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f85fadd4328b3023227ef6758795cbb"><gtr:id>7f85fadd4328b3023227ef6758795cbb</gtr:id><gtr:otherNames>Salanti G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-2802</gtr:issn><gtr:outcomeId>DD08EE793E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CD57128-55EA-4B03-B400-4BE92A4CEE14</gtr:id><gtr:title>Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d486cc7eda5ce0e045910ffcc2e54d4"><gtr:id>4d486cc7eda5ce0e045910ffcc2e54d4</gtr:id><gtr:otherNames>Colbourn TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>63A1FF93022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B85DE4C-8833-4BF2-92D9-E14AA897B981</gtr:id><gtr:title>Heightened risk of false positives in a network meta-analysis of social anxiety--Author's reply.</gtr:title><gtr:parentPublicationTitle>The lancet. Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71f01af3f6c909f75b01813d0b4c00d1"><gtr:id>71f01af3f6c909f75b01813d0b4c00d1</gtr:id><gtr:otherNames>Mayo-Wilson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2215-0366</gtr:issn><gtr:outcomeId>56c1b643702ad1.39578095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F6694B2-F84C-49B9-8514-346A52772C4E</gtr:id><gtr:title>Strategies for efficient computation of the expected value of partial perfect information.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13645c07a180a522f538980c4be6a5f6"><gtr:id>13645c07a180a522f538980c4be6a5f6</gtr:id><gtr:otherNames>Madan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>54610a2c79e902.63617658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>098C2301-E0AD-44B0-B11B-64B01028DB3E</gtr:id><gtr:title>Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd5f5a88b189727f08440f53ef02f97"><gtr:id>6dd5f5a88b189727f08440f53ef02f97</gtr:id><gtr:otherNames>Caldwell DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>pm_12506_26_20080027</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CD50C28-0E77-423A-A3AD-A8BFD4F3A64A</gtr:id><gtr:title>An overview of models used in economic analyses of biologic therapies for arthritis--from current diversity to future consensus.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13645c07a180a522f538980c4be6a5f6"><gtr:id>13645c07a180a522f538980c4be6a5f6</gtr:id><gtr:otherNames>Madan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>pm_12506_26_21859700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FA3FCAE-61CA-4B0F-8F35-DE1E075A2555</gtr:id><gtr:title>Bias in frequently reported analyses of subfertility trials.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>FFcxR8YBiks</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9952EEE-1810-4955-B49A-F575E9E54E04</gtr:id><gtr:title>Simultaneous synthesis of treatment effects and mapping to a common scale: an alternative to standardisation.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>56c1b0337ac5e0.10660778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2769C91-C846-4521-8170-48DE41B0813A</gtr:id><gtr:title>A threshold analysis assessed the credibility of conclusions from network meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd5f5a88b189727f08440f53ef02f97"><gtr:id>6dd5f5a88b189727f08440f53ef02f97</gtr:id><gtr:otherNames>Caldwell DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>58c15b782e58a9.36012600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A1E815C-1229-4F0F-81DE-09ACC1CA0D65</gtr:id><gtr:title>Sensitivity of treatment recommendations to bias in network meta-analysis</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8abdfb4cc6fad19897e2f263b6e5e41"><gtr:id>f8abdfb4cc6fad19897e2f263b6e5e41</gtr:id><gtr:otherNames>Phillippo D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aaa5939d9c8d7.38883363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6973461F-A5F5-4455-81C0-827E4A398FD4</gtr:id><gtr:title>Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>54610b916ffb50.67242439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9AEAA23-8245-48EA-A7B2-6EFA0361A5CD</gtr:id><gtr:title>Research prioritization based on expected value of partial perfect information: a case-study on interventions to increase uptake of breast cancer screening</gtr:title><gtr:parentPublicationTitle>JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62e6b72fb825d286678d1e6c7874bbc5"><gtr:id>62e6b72fb825d286678d1e6c7874bbc5</gtr:id><gtr:otherNames>Welton N. J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-1998</gtr:issn><gtr:outcomeId>FEB00C96C85</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>775013C2-C4E1-46FD-BD7D-CCE3D2BD1D17</gtr:id><gtr:title>Research decisions in the face of heterogeneity: what can a new study tell us?</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72ae2fe192b41cb5e3c10df466797986"><gtr:id>72ae2fe192b41cb5e3c10df466797986</gtr:id><gtr:otherNames>Welton N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>pm_12506_26_22052730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B22C016-361E-441E-9D0F-65B3E9942797</gtr:id><gtr:title>Geographical variation in the provision of elective primary hip and knee replacement: the role of socio-demographic, hospital and distance variables.</gtr:title><gtr:parentPublicationTitle>Journal of public health (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/766538433b036c5ae9f0f6974c0ce0c3"><gtr:id>766538433b036c5ae9f0f6974c0ce0c3</gtr:id><gtr:otherNames>Judge A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1741-3842</gtr:issn><gtr:outcomeId>BDE276FC379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35CCADF5-95B4-4115-AAD4-CCDCA1B4F828</gtr:id><gtr:title>Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials.</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84348f89524b645c7587643627d4774d"><gtr:id>84348f89524b645c7587643627d4774d</gtr:id><gtr:otherNames>Naci H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn><gtr:outcomeId>54610b9097daf6.93490290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B895663F-E23B-4AB4-AA5B-B8B126A3D078</gtr:id><gtr:title>Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84348f89524b645c7587643627d4774d"><gtr:id>84348f89524b645c7587643627d4774d</gtr:id><gtr:otherNames>Naci H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn><gtr:outcomeId>54610b907346f1.95667140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABD63E58-9062-476E-9854-8523373DBB74</gtr:id><gtr:title>Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35a5c7aaf080fd9b65d79c0e702017c8"><gtr:id>35a5c7aaf080fd9b65d79c0e702017c8</gtr:id><gtr:otherNames>Phillippo DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>5aaa59395f7796.99816558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95B9257A-8A81-4B3B-97D0-1101864D4158</gtr:id><gtr:title>Bayesian methods for evidence synthesis in cost-effectiveness analysis.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>89B25534646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1D3D28A-8FC6-4AFC-B31C-16639EC3A1BD</gtr:id><gtr:title>The interpretation of random-effects meta-analysis in decision models.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>3D1E44E57B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9D73DAE-9CA0-48F4-8FF0-BC1A18225382</gtr:id><gtr:title>Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>54610b9010aa39.41083589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAFD2BB5-493E-4603-849E-4FF8D80DCC73</gtr:id><gtr:title>Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular quality and outcomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84348f89524b645c7587643627d4774d"><gtr:id>84348f89524b645c7587643627d4774d</gtr:id><gtr:otherNames>Naci H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1941-7713</gtr:issn><gtr:outcomeId>54610a2ce81c01.07806557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A03242A-127F-4D2A-9DF3-CF2C632E0137</gtr:id><gtr:title>A Bayesian approach to analysing the cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99186fe36784093a89ae67dc4a70fcb"><gtr:id>d99186fe36784093a89ae67dc4a70fcb</gtr:id><gtr:otherNames>Brown J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>B2DC013F7E3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C34D1FC9-2853-4A38-B6AB-CB832989C83C</gtr:id><gtr:title>Meta-analysis of mixed treatment comparisons at multiple follow-up times.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/708ada18da20f695ad331397095f2bf0"><gtr:id>708ada18da20f695ad331397095f2bf0</gtr:id><gtr:otherNames>Lu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>8550632EF23</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FCE63CE-EBD8-454F-AA57-6ADC74B9FEE5</gtr:id><gtr:title>Evaluating novel agent effects in multiple-treatments meta-regression.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f85fadd4328b3023227ef6758795cbb"><gtr:id>7f85fadd4328b3023227ef6758795cbb</gtr:id><gtr:otherNames>Salanti G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>hqxDgDqpi2k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6BC1606-5107-4C5A-8D5B-07825FD169C1</gtr:id><gtr:title>Modeling the need for hip and knee replacement surgery. Part 1. A two-stage cross-cohort approach.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/766538433b036c5ae9f0f6974c0ce0c3"><gtr:id>766538433b036c5ae9f0f6974c0ce0c3</gtr:id><gtr:otherNames>Judge A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>AA6A18AB2CF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF0CBE0D-7765-44EC-BC1B-F4231C517D93</gtr:id><gtr:title>A Bayesian framework to account for uncertainty due to missing binary outcome data in pairwise meta-analysis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33e9ddcbe905dd1d7c412a987c50eced"><gtr:id>33e9ddcbe905dd1d7c412a987c50eced</gtr:id><gtr:otherNames>Turner NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>56c1b643419626.62436003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>377115C5-4C33-43CE-8433-06694A52AFFE</gtr:id><gtr:title>Problem drug use prevalence estimation revisited: heterogeneity in capture-recapture and the role of external evidence.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ea4f380bdda00b56e830cfa03018a1"><gtr:id>93ea4f380bdda00b56e830cfa03018a1</gtr:id><gtr:otherNames>Jones HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>56c1b642200819.56177847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7F9F46C-F55E-4405-A694-3822E603B205</gtr:id><gtr:title>Regional differences in the frequency of the c.985A&amp;gt;G ACADM mutation: findings from a meta-regression of genotyping and screening studies.</gtr:title><gtr:parentPublicationTitle>Clinical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b0669e9e1ad7202d315f3b53701b838"><gtr:id>1b0669e9e1ad7202d315f3b53701b838</gtr:id><gtr:otherNames>Leal J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-9163</gtr:issn><gtr:outcomeId>54610a2c2da0b2.83716897</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U145079307</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>